Total Payments
$1,353
2024 Payments
$56.76
Companies
26
Transactions
70
Medicare Patients
208
Medicare Billing
$16,579
Payment Breakdown by Category
Food & Beverage$1,353 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,353 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $237.87 | 12 | $0 (2023) |
| SK Life Science, Inc. | $146.33 | 6 | $0 (2023) |
| EMD Serono, Inc. | $114.26 | 5 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $87.07 | 4 | $0 (2023) |
| ABBVIE INC. | $84.80 | 5 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $75.16 | 5 | $0 (2022) |
| UCB, Inc. | $73.12 | 4 | $0 (2023) |
| Becton, Dickinson and Company | $57.22 | 3 | $0 (2021) |
| ARGENX US, INC. | $52.20 | 2 | $0 (2023) |
| Bard Access Systems, Inc. | $46.98 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.76 | 3 | Novo Nordisk Inc ($35.26) |
| 2023 | $667.09 | 33 | Novartis Pharmaceuticals Corporation ($166.61) |
| 2022 | $524.77 | 29 | Biohaven Pharmaceutical Holding Company Ltd. ($75.16) |
| 2021 | $104.20 | 5 | Becton, Dickinson and Company ($57.22) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Obesity | ||||||
| 02/15/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: ETONOGESTREL | ||||||
| 04/27/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.97 | General |
| Category: Neuroscience | ||||||
| 04/18/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Neurology | ||||||
| 04/15/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.65 | General |
| 03/31/2023 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Neurology | ||||||
| 03/29/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Neurology | ||||||
| 03/28/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Neurology | ||||||
| 03/28/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.44 | General |
| 03/21/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: Neurology | ||||||
| 03/17/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.90 | General |
| 03/16/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuropsychiatry | ||||||
| 03/16/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: VACCINES | ||||||
| 03/15/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Neurology | ||||||
| 03/14/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Immunology | ||||||
| 03/08/2023 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Neuroscience | ||||||
| 03/08/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 03/06/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Neurology | ||||||
| 03/02/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Neurology | ||||||
| 02/27/2023 | UPSHER-SMITH LABORATORIES LLC | TOSYMRA (Drug), ZEMBRACE SYMTOUCH | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROLOGY | ||||||
| 02/23/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Neurology | ||||||
| 02/21/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 02/13/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Neurology | ||||||
| 02/13/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Adenosine A2A Receptors | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 208 | 326 | $25,926 | $16,579 |
Total Patients
208
Total Services
326
Medicare Billing
$16,579
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 126 | 225 | $20,684 | $13,150 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 47 | $3,053 | $1,939 | 63.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 13 | $1,772 | $1,189 | 67.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 14 | 21 | $251.58 | $199.08 | 79.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 20 | 20 | $164.80 | $101.71 | 61.7% |
About Jennifer Pettit, APRN
Jennifer Pettit, APRN is a Acute Care healthcare provider based in Sallisaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2021. The National Provider Identifier (NPI) number assigned to this provider is 1114599081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Pettit, APRN has received a total of $1,353 in payments from pharmaceutical and medical device companies, with $56.76 received in 2024. These payments were reported across 70 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,353).
As a Medicare-enrolled provider, Pettit has provided services to 208 Medicare beneficiaries, totaling 326 services with total Medicare billing of $16,579. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Sallisaw, OK
- Active Since 07/12/2021
- Last Updated 01/12/2026
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1114599081
Products in Payments
- KESIMPTA (Drug) $163.16
- DUOPA (Drug) $84.80
- NURTEC ODT (Drug) $75.16
- MAYZENT (Drug) $74.71
- Briviact (Drug) $73.12
- MAVENCLAD (Drug) $68.93
- VYVGART (Drug) $52.20
- INGREZZA (Drug) $48.54
- PICC & Midline (Device) $46.98
- Mavenclad (Drug) $45.33
- TOSYMRA (Drug) $42.48
- Ongentys (Drug) $38.53
- Wegovy (Drug) $35.26
- Gamunex-C (Biological) $23.64
- SPINRAZA (Biological) $23.45
- NEXPLANON (Drug) $21.50
- Fycompa (Drug) $21.46
- VALTOCO (Drug) $20.12
- Trudhesa (Drug) $18.94
- Aimovig (Biological) $18.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.